MediniceWAR:ICE +4.87%24 Days Payable is 351.69 as of Mar. 2026, which is 80% below its 10-year median of 1,755.01. GuruFocus rates WAR:ICE with a GF Score™ of 24/100 and a GF Value™ of zł0.99 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, Medinice ranks better than 97.11% on this metric.
Medinice's average Accounts Payable for the
three
months ended in Mar. 2026 was zł0.28 Mil. Medinice's Cost of Goods Sold for the
three
months ended in Mar. 2026 was zł0.07 Mil.
Hence, Medinice's Days Payable for the
three
months ended in Mar. 2026 was 351.69.
The historical rank and industry rank for Medinice's Days Payable or its related term are showing as below:
WAR:ICE'
s Days Payable Range Over the Past 10 Years
Min: 1168.99 Med: 1755.01 Max: 7060.86
Current: 2011.95
During the past 10 years, Medinice's highest Days Payable was 7060.86. The lowest was 1168.99. And the median was 1755.01.
WAR:ICE's Days Payable is ranked better than 97.11% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs WAR:ICE: 2011.95
Medinice's Days Payable
declined
from Mar. 2025 (4,030.21) to Mar. 2026 (351.69).
It may suggest that Mediniceaccelerated paying its suppliers.
Medinice Days Payable Related Terms
Medinice Days Payable Historical Data
* Premium members only.
The historical data trend for Medinice's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medinice's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinice Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medinice's Days Payable distribution charts can be found below:
* The bar in red indicates where Medinice's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medinice's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinice (WAR:ICE) has a Days Payable of 351.69 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medinice and its competitors. This is 80% below median its historical median of 1,755.01. Over the past decade, Medinice's Days Payable has ranged from 1,168.99 to 7,060.86. According to the industry distribution chart, Medinice ranks #23 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 2.9%.
Is Medinice's Days Payable too high?
Medinice's current Days Payable of 351.69 is 80% below median its 10-year median of 1,755.01. Over the past 10 years, this metric has ranged from a low of 1,168.99 to a high of 7,060.86. The Medical Devices & Instruments industry median Days Payable is 68.07. Medinice's value of 351.69 is 416.7% above this industry median. Based on the distribution chart, Medinice ranks #23 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medinice has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medinice's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medinice ranks #23 out of 795 companies for Days Payable. This places Medinice in the top 3% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Medinice's value of 351.69 is 416.7% above this benchmark. Historically, Medinice's own Days Payable has ranged from 1,168.99 to 7,060.86 over the past decade. While the company's 10-year median is 1,755.01 vs. the industry median of 68.07, Medinice has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinice's current Days Payable of 351.69 is 416.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medinice and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinice's current Days Payable is 351.69, which is 80% below median its own 10-year median of 1,755.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinice stock overvalued right now?
Based on GuruFocus' analysis, Medinice (WAR:ICE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.99, compared to a current price of zł79.70 — trading 7950.5% above its estimated fair value. The current Days Payable is 351.69, which is 80% below median its 10-year median of 1,755.01 and 416.7% above the Medical Devices & Instruments industry median of 68.07. Medinice's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medinice (WAR:ICE), the current Days Payable is 351.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinice (WAR:ICE) Overvalued in 2026?
Based on GuruFocus' analysis, Medinice stock appears to be overvalued.
The current stock price of zł79.70 is trading 7950.5% above its estimated GF Value™ of zł0.99.
GuruFocus considers Medinice to be Significantly Overvalued.
Key valuation signals for WAR:ICE:
Days Payable: 351.69 (80% below median its 10-year median of 1,755.01)
GF Value™: zł0.99 vs. price of zł79.70 (7950.5% above fair value)
Industry Position: 416.7% above the Medical Devices & Instruments median (#23 of 795)
No single metric tells the full story. See the WAR:ICE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.
24GF Score
Get the complete analysis for WAR:ICE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ICE has been successfully added to your 
